Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Greaf Biotech is a leading global developer and manufacturer of active ingredients for the personal care and cosmetic industries. Established in 2010, the company utilizes advanced biotechnology, including plant extraction, bio-fermentation, and synthetic peptides, to create high-efficacy skincare solutions. Their portfolio focuses on key areas such as anti-aging, skin whitening, moisturizing, and anti-inflammation, serving major international beauty brands. Greaf operates state-of-the-art R&D centers and manufacturing facilities that adhere to global quality standards like EFfCI GMP. The company is particularly noted for its innovation in integrating traditional Chinese medicinal knowledge with modern biotechnological processes. By maintaining a strong focus on scientific research and quality control, Greaf has established itself as a key supplier for the global cosmeceutical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greaf.